Cargando…
Macroprolactinoma with secondary resistance to dopamine agonists: a case report and review of the literature
BACKGROUND: Resistance to dopamine agonists is not uncommonly seen in prolactinomas. However, development of resistance to dopamine agonists after an initial period of robust treatment response is rare, and only 39 cases have been reported in the past four decades. We describe a Chinese man with thi...
Autores principales: | Tng, Eng-Loon, Teo, Ada Ee Der, Aung, Aye Thida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021939/ https://www.ncbi.nlm.nih.gov/pubmed/36927797 http://dx.doi.org/10.1186/s13256-023-03820-5 |
Ejemplares similares
-
SAT-260 Resolution of a Cystic Macroprolactinoma with Dopamine Agonist Therapy
por: Ansari, Mohammad Jamal Uddin, et al.
Publicado: (2020) -
Efficacy and safety of anticoagulation in thyrotoxic atrial fibrillation: a systematic review and meta-analysis
por: Tng, Eng-Loon, et al.
Publicado: (2022) -
SUN-444 Efficacy and Safety of Dopamine Agonists in Psychiatric Patients Treated with Antipsychotics and Presenting a Macroprolactinoma
por: Allard, Lucie, et al.
Publicado: (2019) -
Myxedema Coma Associated with Macroprolactinoma: Case Report and Review of the Literature
por: Omoniyi, Elizabeth Jasola, et al.
Publicado: (2022) -
Management of macroprolactinomas
por: Tirosh, Amit, et al.
Publicado: (2015)